查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1671185

抗凝固劑反轉藥的全球市場:市場規模·佔有率·趨勢，產業分析 (各產品·各流通管道·各地區)，未來預測 (2025年～2034年)

Anticoagulant Reversal Drugs Market Share, Size, Trends, Industry Analysis Report - By Product, Distribution Channel, and Region - Market Forecast, 2025-2034
出版日期: | 出版商: Polaris Market Research | 英文 116 Pages | 商品交期: 最快1-2個工作天內

價格

根據 Polaris Market Research 的最新研究，抗凝血逆轉藥物市場規模預計到 2034 年將達到 4,486,470 億美元。該報告提供了對當前市場動態的詳細見解，並對未來市場成長進行了分析。

心房顫動和心臟病等心血管疾病在世界各地變得越來越常見。患有這些疾病的患者需要服用抗凝血劑（血液稀釋劑）來預防血栓。然而，抗凝血劑在某些情況下可能會增加過度出血的風險，因此需要抗凝血逆轉劑來控制潛在的出血併發症。心血管疾病患者數量的不斷增加促使對這些逆轉藥物的需求增加。因此，確保患者在治療期間的安全是治療過程的重要部分。心血管疾病盛行率的不斷上升直接推動了抗凝血逆轉藥物市場的需求。

FDA 等監管機構對新型有效抗凝血逆轉藥物的批准正在推動抗凝血逆轉藥物市場的成長。 FDA 批准確保藥物對公眾使用是安全有效的，並在醫療保健提供者和患者之間建立信任。隨著新型逆轉藥物的推出和批准，醫生將擁有更多的治療選擇，並能夠為每位患者選擇最合適的藥物。核准藥物數量的增加將鼓勵醫療保健系統採用這些新療法，從而刺激市場。此類藥物的持續批准有助於滿足日益增長的醫療保健需求，並促進抗凝血逆轉藥物市場的發展。

抗凝血逆轉藥物市場報告重點

根據產品，idarucizumab 部門在 2024 年佔據了抗凝血逆轉藥物市場佔有率的主導地位，因為它在逆轉常見血液稀釋劑達比加群的作用方面具有很高的功效和特異性。

由於因出血性疾病住院的患者數量不斷增加，醫院藥房市場佔據最大的市場佔有率。

由於直接報銷政策的可用性和該地區先進的醫療保健行業等因素，預計北美將在 2024 年佔據整個抗凝血逆轉劑市場的收入佔有率的主導地位。

由於醫療保健投資的增加和對血液稀釋治療的認識的提高，亞太地區的抗凝血逆轉藥物市場正在經歷顯著增長。

全球市場參與者包括 Alps Pharmaceutical Ind.Ltd.、AMAG Pharmaceuticals, Inc.、Bausch Health Companies Inc.、Boehringer Ingelheim、CSL Behring、Dr. Reddy's Laboratories、Fresenius Kabi AG、Octapharma AG、Pfizer, Inc.s 和 Pharmaceutical。以及久光製藥株式會社

目錄

第1章 簡介

第2章 摘要整理

第3章 分析方法

第4章 全球抗凝固劑反轉藥市場洞察

  • 市場概述
  • 抗凝固劑反轉藥的市場動態
    • 促進因素和機會
      • 擴大研究活動
      • 老年人口增加
    • 阻礙因素和課題
      • 監理障礙
  • 大環境分析
  • 抗凝固劑反轉藥市場趨勢
  • 價值鏈分析
  • COVID-19影響分析

第5章 全球抗凝固劑反轉藥市場:各產品

  • 主要發現
  • 簡介
  • 凝血酶原複合物濃縮物
  • 植物甲萘醌
  • Andexanet Alpha
  • 伊達賽珠單抗
  • 魚精蛋白

第6章 全球抗凝固劑反轉藥市場:各流通管道

  • 主要的分析結果
  • 簡介
  • 醫院藥局
  • 零售藥局
  • 線上藥局

第7章 全球抗凝固劑反轉藥市場:各地區

  • 主要的分析結果
  • 簡介
    • 抗凝固劑反轉藥市場評估:各地區 (2020～2034年)
  • 北美
    • 北美:各產品 (2020～2034年)
    • 北美:各流通管道 (2020～2034年)
    • 美國
    • 加拿大
  • 歐洲
    • 歐洲:各產品 (2020～2034年)
    • 歐洲:各流通管道 (2020～2034年)
    • 英國
    • 法國
    • 德國
    • 義大利
    • 西班牙
    • 荷蘭
    • 俄羅斯
    • 其他歐洲
  • 亞太地區
    • 亞太地區:各產品 (2020～2034年)
    • 亞太地區:各流通管道 (2020～2034年)
    • 中國
    • 印度
    • 馬來西亞
    • 日本
    • 印尼
    • 韓國
    • 澳洲
    • 其他亞太地區
  • 中東·非洲
    • 中東·非洲:各產品 (2020～2034年)
    • 中東·非洲:各流通管道 (2020～2034年)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東·非洲
  • 南美
    • 南美:各產品 (2020～2034年)
    • 南美:各流通管道 (2020～2034年)
    • 墨西哥
    • 巴西
    • 阿根廷
    • 其他南美國家

第8章 競爭情形

  • 事業擴大·企業收購的分析
    • 事業擴大
    • 企業收購
  • 聯盟/合作/協定/公開

第9章 企業簡介

  • Alps Pharmaceutical Ind. Co., Ltd.
  • AMAG Pharmaceuticals, Inc.
  • Bausch Health Companies Inc.
  • Boehringer Ingelheim
  • CSL Behring
  • Dr. Reddy's Laboratories
  • Fresenius Kabi AG
  • Octapharma AG
  • Pfizer, Inc.
  • Portola Pharmaceuticals
  • Covis Pharma
  • Hisamitsu Pharmaceutical Co., Inc.
Product Code: PM1869

The anticoagulant reversal drugs market size is expected to reach USD 4,486.47 million by 2034, according to a new study by Polaris Market Research. The report "Anticoagulant Reversal Drugs Market Share, Size, Trends, Industry Analysis Report - By Product (Prothrombin Complex Concentrates, Phytonadione, Andexanet Alfa, Idarucizumab, Protamine, and Others), Distribution Channel, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Cardiovascular diseases, such as atrial fibrillation and heart attacks, are becoming common worldwide. Patients having these conditions require anticoagulants (blood thinners) to prevent blood clots. However, anticoagulants can increase the risk of excessive bleeding in some cases, creating a need for anticoagulant reversal drugs to manage potential bleeding complications. The growing number of individuals affected by cardiovascular conditions leads to an increased demand for these reversal drugs. This makes them an essential part of the treatment process, ensuring patient safety during therapy. The rise in the prevalence of cardiovascular diseases is directly driving the anticoagulant reversal drugs market demand.

The approval of new and effective anticoagulant reversal drugs by regulatory authorities such as the FDA is driving the anticoagulant reversal drug market growth. FDA approval ensures that a drug is safe and effective for public use, which builds trust among healthcare providers and patients. When new reversal drugs are introduced and approved, they provide more treatment options for doctors, allowing them to select the most appropriate medicine for each patient. This increased availability of approved drugs stimulates the market as healthcare systems adopt these newer treatments. The continuous approval of such drugs helps meet the growing healthcare demand, driving the anticoagulant reversal drugs market development.

Anticoagulant Reversal Drugs Market Report Highlights

By product, the idarucizumab segment dominated the anticoagulant reversal drugs market share in 2024 due to its high efficacy and specificity in reversing the effects of dabigatran, a common blood thinner.

The hospital pharmacy segment, based on distribution channel, accounts for the largest market share due to rising hospital admissions for distinct types of bleeding disorders.

In 2024, North America dominated the overall anticoagulant reversal drugs market revenue share due to factors such as the availability of direct refund policies and the region's advanced healthcare sector.

The Asia Pacific anticoagulant reversal drug market is experiencing significant growth due to increasing healthcare investments and rising awareness about blood thinning treatments.

A few global market players include Alps Pharmaceutical Ind. Co., Ltd.; AMAG Pharmaceuticals, Inc.; Bausch Health Companies Inc.; Boehringer Ingelheim; CSL Behring; Dr. Reddy's Laboratories; Fresenius Kabi AG; Octapharma AG; Pfizer, Inc.; Portola Pharmaceuticals; Covis Pharma.; and Hisamitsu Pharmaceutical Co., Inc.

Polaris Market Research has segmented the anticoagulant reversal drugs market report on the basis of product, distribution channel, and region:

By Product Outlook (Revenue - USD Million, 2020-2034)

  • Prothrombin Complex Concentrates
  • Phytonadione
  • Andexanet Alfa
  • Idarucizumab
  • Protamine

By Distribution Channel Outlook (Revenue - USD Million, 2020-2034)

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By Regional Outlook (Revenue - USD Million, 2020-2034)

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Australia
  • Vietnam
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Anticoagulant Reversal Drugs Market Insights

  • 4.1. Anticoagulant Reversal Drugs Market - Market Snapshot
  • 4.2. Anticoagulant Reversal Drugs Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Increasing Research Activities
      • 4.2.1.2. Rise in Geriatric Population
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Regulatory Hurdle
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Anticoagulant Reversal Drugs Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Anticoagulant Reversal Drugs Market, by Product

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • 5.3. Prothrombin Complex Concentrates
    • 5.3.1. Global Anticoagulant Reversal Drugs Market, by Prothrombin Complex Concentrates, by Region, 2020-2034 (USD Million)
  • 5.4. Phytonadione
    • 5.4.1. Global Anticoagulant Reversal Drugs Market, by Phytonadione, by Region, 2020-2034 (USD Million)
  • 5.5. Andexanet Alfa
    • 5.5.1. Global Anticoagulant Reversal Drugs Market, by Andexanet Alfa, by Region, 2020-2034 (USD Million)
  • 5.6. Idarucizumab
    • 5.6.1. Global Anticoagulant Reversal Drugs Market, by Idarucizumab, by Region, 2020-2034 (USD Million)
  • 5.7. Protamine
    • 5.7.1. Global Anticoagulant Reversal Drugs Market, by Protamine, by Region, 2020-2034 (USD Million)

6. Global Anticoagulant Reversal Drugs Market, by Distribution Channel

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 6.3. Hospital Pharmacy
    • 6.3.1. Global Anticoagulant Reversal Drugs Market, by Hospital Pharmacy, by Region, 2020-2034 (USD Million)
  • 6.4. Retail Pharmacy
    • 6.4.1. Global Anticoagulant Reversal Drugs Market, by Retail Pharmacy by Region, 2020-2034 (USD Million)
  • 6.5. Online Pharmacy
    • 6.5.1. Global Anticoagulant Reversal Drugs Market, by Online Pharmacy by Region, 2020-2034 (USD Million)

7. Global Anticoagulant Reversal Drugs Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Anticoagulant Reversal Drugs Market Assessment, By Geography, 2020-2034 (USD Million)
  • 7.3. Anticoagulant Reversal Drugs Market - North America
    • 7.3.1. North America: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
    • 7.3.2. North America: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.3.3. Anticoagulant Reversal Drugs Market - U.S.
      • 7.3.3.1. U.S.: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.3.3.2. U.S.: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.3.4. Anticoagulant Reversal Drugs Market - Canada
      • 7.3.4.1. Canada: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.3.4.2. Canada: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 7.4. Anticoagulant Reversal Drugs Market - Europe
    • 7.4.1. Europe: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
    • 7.4.2. Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.3. Anticoagulant Reversal Drugs Market - UK
      • 7.4.3.1. UK: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.3.2. UK: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.4. Anticoagulant Reversal Drugs Market - France
      • 7.4.4.1. France: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.4.2. France: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.5. Anticoagulant Reversal Drugs Market - Germany
      • 7.4.5.1. Germany: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.5.2. Germany: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.6. Anticoagulant Reversal Drugs Market - Italy
      • 7.4.6.1. Italy: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.6.2. Italy: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.7. Anticoagulant Reversal Drugs Market - Spain
      • 7.4.7.1. Spain: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.7.2. Spain: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.8. Anticoagulant Reversal Drugs Market - Netherlands
      • 7.4.8.1. Netherlands: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.8.2. Netherlands: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.9. Anticoagulant Reversal Drugs Market - Russia
      • 7.4.9.1. Russia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.9.2. Russia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.4.10. Anticoagulant Reversal Drugs Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.4.10.2. Rest of Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 7.5. Anticoagulant Reversal Drugs Market - Asia Pacific
    • 7.5.1. Asia Pacific: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
    • 7.5.2. Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.3. Anticoagulant Reversal Drugs Market - China
      • 7.5.3.1. China: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.3.2. China: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.4. Anticoagulant Reversal Drugs Market - India
      • 7.5.4.1. India: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.4.2. India: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.5. Anticoagulant Reversal Drugs Market - Malaysia
      • 7.5.5.1. Malaysia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.5.2. Malaysia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.6. Anticoagulant Reversal Drugs Market - Japan
      • 7.5.6.1. Japan: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.6.2. Japan: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.7. Anticoagulant Reversal Drugs Market - Indonesia
      • 7.5.7.1. Indonesia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.7.2. Indonesia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.8. Anticoagulant Reversal Drugs Market - South Korea
      • 7.5.8.1. South Korea: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.8.2. South Korea: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.9. Anticoagulant Reversal Drugs Market - Australia
      • 7.5.9.1. Australia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.9.2. Australia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.5.10. Anticoagulant Reversal Drugs Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.5.10.2. Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 7.6. Anticoagulant Reversal Drugs Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
    • 7.6.2. Middle East & Africa: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.6.3. Anticoagulant Reversal Drugs Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.6.3.2. Saudi Arabia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.6.4. Anticoagulant Reversal Drugs Market - UAE
      • 7.6.4.1. UAE: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.6.4.2. UAE: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.6.5. Anticoagulant Reversal Drugs Market - Israel
      • 7.6.5.1. Israel: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.6.5.2. Israel: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.6.6. Anticoagulant Reversal Drugs Market - South Africa
      • 7.6.6.1. South Africa: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.6.6.2. South Africa: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.6.7. Anticoagulant Reversal Drugs Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.6.7.2. Rest of Middle East & Africa: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • 7.7. Anticoagulant Reversal Drugs Market - Latin America
    • 7.7.1. Latin America: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
    • 7.7.2. Latin America: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.7.3. Anticoagulant Reversal Drugs Market - Mexico
      • 7.7.3.1. Mexico: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.7.3.2. Mexico: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.7.4. Anticoagulant Reversal Drugs Market - Brazil
      • 7.7.4.1. Brazil: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.7.4.2. Brazil: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.7.5. Anticoagulant Reversal Drugs Market - Argentina
      • 7.7.5.1. Argentina: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.7.5.2. Argentina: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
    • 7.7.6. Anticoagulant Reversal Drugs Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
      • 7.7.6.2. Rest of Latin America: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Alps Pharmaceutical Ind. Co., Ltd.
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. AMAG Pharmaceuticals, Inc.
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Bausch Health Companies Inc.
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Boehringer Ingelheim
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. CSL Behring
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Dr. Reddy's Laboratories
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. Fresenius Kabi AG
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Octapharma AG
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. Pfizer, Inc.
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Portola Pharmaceuticals
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development
  • 9.11. Covis Pharma
    • 9.11.1. Company Overview
    • 9.11.2. Financial Performance
    • 9.11.3. Product Benchmarking
    • 9.11.4. Recent Development
  • 9.12. Hisamitsu Pharmaceutical Co., Inc.
    • 9.12.1. Company Overview
    • 9.12.2. Financial Performance
    • 9.12.3. Product Benchmarking
    • 9.12.4. Recent Development

List of Tables:

  • Table 1 Global Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 2 Global Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 3 North America: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 4 North America: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 5 U.S.: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 6 U.S.: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 7 Canada: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 8 Canada: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 9 Europe: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 10 Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 11 UK: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 12 UK: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 13 France: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 14 France: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 15 Germany: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 16 Germany: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 17 Italy: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 18 Italy: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 19 Spain: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 20 Spain: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 21 Netherlands: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 22 Netherlands: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 23 Russia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 24 Russia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 25 Rest of Europe: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 26 Rest of Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 27 Asia Pacific: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 28 Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 29 China: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 30 China: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 31 India: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 32 India: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 33 Malaysia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 34 Malaysia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 35 Japan: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 36 Japan: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 37 Indonesia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 38 Indonesia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 39 South Korea: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 40 South Korea: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 41 Australia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 42 Australia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 43 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 44 Rest of Asia Pacific: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 45 Middle East & Africa: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 46 Middle East & Africa: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 47 Saudi Arabia: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 48 Saudi Arabia: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 49 UAE: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 50 UAE: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 51 Israel: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 52 Israel: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 53 South Africa: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 54 South Africa: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 55 Rest of Middle East & Africa: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 56 Rest of Middle East & Africa: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 57 Latin America: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 58 Latin America: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 59 Mexico: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 60 Mexico: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 61 Brazil: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 62 Brazil: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 63 Argentina: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 64 Argentina: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)
  • Table 65 Rest of Latin America: Anticoagulant Reversal Drugs Market, by Product, 2020-2034 (USD Million)
  • Table 66 Rest of Latin America: Anticoagulant Reversal Drugs Market, by Distribution Channel, 2020-2034 (USD Million)

List of Figures:

  • Figure 1. Global Anticoagulant Reversal Drugs Market, 2020-2034 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Product
  • Figure 7. Global Anticoagulant Reversal Drugs Market, by Product, 2024 & 2034 (USD Million)
  • Figure 8. Market by Distribution Channel
  • Figure 9. Global Anticoagulant Reversal Drugs Market, by Distribution Channel, 2024 & 2034 (USD Million)